Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE MKT LLC:OGEN)

2.26
Delayed Data
As of Aug 31
 +0.04 / +1.80%
Today’s Change
0.66
Today|||52-Week Range
3.87
+154.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues201.0K220.5K361.8K242.0K
 
 
 
 
 
Cost of Goods Sold66.9K83.0K154.1K68.2K
 
 
 
 
 
Depreciation And Amortization6.8K7.5K13.9K18.6K
 
 
 
 
 
 
Operating ExpensesGross Income127.3K130.0K193.8K155.3K
 
 
 
 
 
General Expenses1.2M1.4M1.5M6.5M
 
 
 
 
 
Research And Development597.0K548.2K676.6K5.6M
 
 
 
 
 
Total Operating Expenses1.2M1.5M1.7M6.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.0M-1.2M-1.3M-6.3M
 
 
 
 
 
Interest Expense On Debt1.3K1.2K606.0010.0K
 
 
 
 
 
Other Expenses-2.0K-49.00-504.00-900.00
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.0M-1.2M-1.3M-6.3M
 
 
 
 
 
Net Income-1.0M-1.2M-1.3M-6.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.2M36.2M36.2M36.4M
 
 
 
 
 
Shares To Calculate EPS Diluted36.2M36.2M36.2M36.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.03-$0.04-$0.17
 
 
 
 
 
EPS Diluted-$0.03-$0.03-$0.04-$0.17